A detailed history of Centiva Capital, LP transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Centiva Capital, LP holds 9,899 shares of AVNS stock, worth $158,581. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,899
Previous 16,166 38.77%
Holding current value
$158,581
Previous $322,000 26.4%
% of portfolio
0.0%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$19.21 - $24.69 $120,389 - $154,732
-6,267 Reduced 38.77%
9,899 $237,000
Q2 2024

Aug 14, 2024

BUY
$17.85 - $20.42 $288,563 - $330,109
16,166 New
16,166 $322,000
Q1 2022

May 16, 2022

SELL
$28.87 - $35.77 $222,963 - $276,251
-7,723 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$29.25 - $36.02 $30,712 - $37,821
1,050 Added 15.74%
7,723 $268,000
Q3 2021

Nov 15, 2021

BUY
$31.2 - $38.5 $208,197 - $256,910
6,673 New
6,673 $207,000

Others Institutions Holding AVNS

About AVANOS MEDICAL, INC.


  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $745M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.